
Johnson & Johnson TB drug price reduced
MSF has pushed J&J for years to lower the price of its lifesaving TB drug bedaquiline The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes Johnson & Johnson’s (J&J) announcement today to reduce the price of its tuberculosis (TB) drug bedaquiline to $1.50 per day. Governments must now urgently scale up the use…